Skip to main content
SpringerLink
Log in

Hydrolysis of methotrexate-immunoglobulin conjugates by liver homogenates and characterization of catabolites

  • Short Communication
  • Hydrolysis, Methotrexate Immunoglobulin Conjugates, Catabolites
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Methotrexate (MTX) linked to antitumor antibodies inhibits tumor growth better than free MTX, free antibody, or MTX linked to normal rabbit IgG (NRG), in spite of the less effective inhibition of the target enzyme dihydrofolate reductase (DHFR) by conjugated MTX. In addition to the demonstrated higher uptake of MTX linked to antitumor antibodies (compared with the uptake of free MTX or nonspecific IgG conjugates), a contributory factor to the superior tumor inhibitory action of MTX-IgG conjugates may be the prolonged release of active drug from the internalized conjugate. Therefore, we have investigated whether an MTX-IgG conjugate could be hydrolyzed to release free MTX or fully active MTX-containing fragments after incubation with liver homogenates and have characterized the catabolites according to the presence of free MTX and their capacity to inhibit DHFR. Catabolism was optimal at pH 4.6, activated by dithiothreitol, and inhibited by antipain and N-α-p-tosyl-l-lysine chloromethyl ketone, thus implicating lysosomal enzymes. Liver homogenates produced an MTX-containing, lowmolecular-weight fraction that was isolated by gel filtration. Further purification of this fraction by DEAE-cellulose chromatography gave two MTX-containing peaks, neither of which migrated as free MTX on thin-layer chromatography or inhibited DHFR more effectively than the parent conjugate. However, the presence of amino acid residues in these catabolites could contribute to their observed prolonged intracellular retention and superior antitumor action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Baugh CM, Krumdiock CL, Nair MG (1973) Polygammaglutamyl metabolites of methotrexate. Biochem Biophys Res Commun 53:27

    Google Scholar 

  2. Ghose T, Blair AH (1987) The design of cytotoxic-agent antibody conjugates. CRC Crit Rev Ther Drug Carrier Syst 3:263

    Google Scholar 

  3. Ghose T, Blair AH, Uadia P, Kulkarni PN, Goundalkar A, Mezei M, Ferrone S (1985) Antibodies as carriers of cancer chemotherapeutic agents. Ann NY Acad Sci 446:213

    Google Scholar 

  4. Ghose T, Blair AH, Kralovec J, Mammen M (1988) Synthesis and testing of antifolate conjugates for drug targeting. In: Rodwell JD (ed) Targeted diagnosis and therapy. Marcel Dekker (in press)

  5. Goldman ID (1975) Analysis of the cytotoxic determinants for methotrexate (NSC-740): a role for free intracellular drug. Cancer Chemother Rep 6 (3):51

    Google Scholar 

  6. Johns DG, Bertino JR (1982) Folate antagonists. In: Holland JF, Frei E III (eds) Cancer Medicine, 2nd Ed. Lea and Faebiger, Philadelphia, p 775

    Google Scholar 

  7. Kulkarni PN, Blair AH, Ghose T (1981) Covalent binding of methotrexate to immunoglobulins and the effect of antibodylinked drug on tumor growth in vivo. Cancer Res 41:2700

    Google Scholar 

  8. Peterson DL, Gleisner JMM, Blakley RL (1975) Bovine liver dihydrofolate reductase: Purification and properties of the enzyme. Biochemistry 14:5261

    Google Scholar 

  9. Silber R, Heunnekens FM, Gabrio BW (1963) Studies on the interaction of tritium-labeled aminopterin with dihydrofolic reductase. Arch Biochem Biophys 100:525

    Google Scholar 

  10. Uadia P, Blair AH, Ghose T (1983) Uptake of methotrexate linked to an anti-EL4-lymphoma antibody by EL4 cells. Cancer Immunol Immunother 16:127

    Google Scholar 

  11. Uadia P, Blair AH, Ghose T (1984) Tumor and tissue distribution of a methotrexate-anti-EL4 immunoglobulin conjugate in EL4 lymphoma-bearing mice. Cancer Res 44:4263

    Google Scholar 

  12. Uadia P, Blair AH, Ghose T, Ferrone S (1985) Uptake of methotrexate linked to polyclonal and monoclonal antimelanoma antibodies by a human melanoma cell line. J Nat Cancer Inst 74:29

    Google Scholar 

Download references

Author information

Author notes

  1. P. O. Uadia

    Present address: Department of Biochemistry, University of Port Harcourt, Port Harcourt, Nigeria

Authors and Affiliations

  1. Department of Biochemistry, Dalhousie University, B3H 4H7, Halifax, Nova Scotia, Canada

    P. O. Uadia & A. H. Blair

  2. Department of Pathology, Dalhousie University, B3H 4H7, Halifax, Nova Scotia, Canada

    T. Ghose

Authors
  1. P. O. Uadia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. H. Blair
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Ghose
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by grants [MA 9725 and MA 10008] from the Medical Research Council of Canada

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uadia, P.O., Blair, A.H. & Ghose, T. Hydrolysis of methotrexate-immunoglobulin conjugates by liver homogenates and characterization of catabolites. Cancer Chemother. Pharmacol. 22, 175–177 (1988). https://doi.org/10.1007/BF00257318

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00257318

Keywords

Search

Navigation